Release Date: November 17th, 2016
Expiration date: May 18th, 2017
Estimated Time to Complete Activity: 25 minutes
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
OVERVIEW
In this webcast, Dr. Vinod Thourani, Dr. Howard Herrmann, and Dr. Michael Reardon discuss the latest findings on the expanded indications of transcatheter aortic valve replacement (TAVR) in intermediate risk and high risk patients, the implications for patient care, and insights into what this means for referring cardiologists. The panel also discusses their firsthand experience with TAVR and the benefits of the Heart Team.
LEARNING OBJECTIVES
After participating in this event, learners will be able to:
1. Discuss the outcomes of the latest data from multiple trials
2. Describe the benefits of having a strong Heart Team
3. Explore the changes to TAVR and the indications from the latest data
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other health care professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
DISCLOSURE SUMMARY
KEY: (G/R), Grant Support/Research Contract; (C/H/S), Consultant Fee/Honoraria/Speaker’s Bureau; (E), Equity; (R/I), Royalty/Intellectual Property Rights; (S), Salary/Salary Support; (O), Other Financial Benefit
Faculty
Vinod H. Thourani, MD
(G/R) Abbott, Edwards Lifesciences, Boston Scientific, Medtronic, St. Jude Medical (C/H/S) Abbott, Edwards Lifesciences, St. Jude Medical, Medtronic
Howard C. Herrmann, MD
(G/R) Edwards Lifesciences, Medtronic, Boston Scientific, St. Jude Medical, Abbott (C/H/S) Edwards Lifesciences
Michael J. Reardon, MD
(C/H/S) Medtronic
Planning Committee
Arielle Gelardi (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through an educational grant from Edwards Lifesciences and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Arielle Geraldi at agelardi@crf.org